MRK: third_quarter 2026 lobbying report

{"url":"https://lda.gov/api/v1/filings/b02d8d12-6cfa-49f7-8039-12911dfae48d/","filing_uuid":"b02d8d12-6cfa-49f7-8039-12911dfae48d","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/b02d8d12-6cfa-49f7-8039-12911dfae48d/print/","filing_document_content_type":"text/html","income":null,"expenses":"2390000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Brad Tallamy","dt_posted":"2026-10-20T17:25:49-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"126 E Lincoln Avenue","registrant_address_2":"P.O. Box 2000","registrant_different_address":false,"registrant_city":"Rahway","registrant_state":"NJ","registrant_zip":"07065","registrant":{"id":24908,"url":"https://lda.gov/api/v1/registrants/24908/","house_registrant_id":31304,"name":"MERCK & CO, INC.","description":null,"address_1":"126 E Lincoln Avenue","address_2":"P.O. Box 2000","address_3":null,"address_4":null,"city":"Rahway","state":"NJ","state_display":"New Jersey","zip":"07065","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"BRAD TALLAMY","contact_telephone":"+1 202-508-4545","dt_updated":"2026-07-30T11:53:36.976270-04:00"},"client":{"id":132602,"url":"https://lda.gov/api/v1/clients/132602/","client_id":12,"name":"MERCK & CO INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-13"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S. 2076, Pioneering Antimicrobial Subscriptions To End Upsurging Resistance (PASTEUR) Act of 2021 Issues relating to, 340B program integrity; 340B of the Public Health Services Act; Drug pricing and reimbursement issues; Vaccine issues; Pharmaceutical supply channel issues; Drug shortages issues; Inflation Reduction Act (P.L. 117-169), issues relating to drug pricing provisions; FY-2027 Budget and Appropriations Legislation; Budget reconciliation drug pricing provisions; Commerce Justice, Science, and related agencies appropriations legislation for 2026; Interior, Environment, and related agencies appropriations legislation for 2026; Intellectual property and trade issues; International competition in biopharmaceuticals.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":119825,"prefix":null,"prefix_display":null,"first_name":"BRADFORD","nickname":null,"middle_name":null,"last_name":"TALLAMY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149596,"prefix":null,"prefix_display":null,"first_name":"STEPHANIE","nickname":null,"middle_name":null,"last_name":"MCBATH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153657,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"RADDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154457,"prefix":null,"prefix_display":null,"first_name":"CHARLES","nickname":null,"middle_name":null,"last_name":"CLAPTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues relating to, 340B program integrity; 340B of the Public Health Services Act; Drug pricing and reimbursement issues.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":119825,"prefix":null,"prefix_display":null,"first_name":"BRADFORD","nickname":null,"middle_name":null,"last_name":"TALLAMY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153657,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"RADDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154457,"prefix":null,"prefix_display":null,"first_name":"CHARLES","nickname":null,"middle_name":null,"last_name":"CLAPTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"ANI","general_issue_code_display":"Animals","description":"Issues relating to, Agriculture, Rural Development , Food and Drug Administration, and Related Agencies Appropriations Bill; Commerce, Justice, Science, and Related Agencies Appropriations Bill, 2026; Interior, Environment, and Related Agencies Appropriations Bill 2026; United States Department of Agriculture, Animal and Plant Health Inspection Service, Final Rule: Use of Electronic Identification Ear tags as Official Identification in Cattle and Bison.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":149596,"prefix":null,"prefix_display":null,"first_name":"STEPHANIE","nickname":null,"middle_name":null,"last_name":"MCBATH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154457,"prefix":null,"prefix_display":null,"first_name":"CHARLES","nickname":null,"middle_name":null,"last_name":"CLAPTON","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}